Your Messages Inbox
Your Article Summary
See Latest ArticlesCytokinetics Announces Non-clinical Data Relating to GSK-923295 Presented at the 2009 American Association of Cancer Research Annual Meeting
Cytokinetics, 04/23/09
Cytokinetics, Incorporated announced that two abstracts containing non-clinical data relating to GSK-923295, a novel inhibitor of centromere-associated protein E (CENP-E), were presented at the 2009 American Association of Cancer Research (AACR) Annual Meeting held from April 18 - 22, 2009 in Denver, CO. One poster detailed findings of a pharmacokinetic assessment of GSK-923295 and the other poster detailed pre-clinical assessments of GSK-923295 in breast cancer cells.
Today in Conferences/Meetings...keeping you current
Receive free subspecialty "5-minute updates" via email
ImmunoGen, Inc. Announces Conference Call to Discuss Clinical Data Reported at Recent Medical Meetings
ImmunoGen, Inc., 12/04/09
Allos Therapeutics to Launch Global Registry for Patients with Peripheral T-Cell Lymphoma at the American Society of Hematology Annual Meeting
Allos Therapeutics, 12/04/09
Cytokinetics Announces Non-Clinical Data Relating to GSK-923295 to be Presented at the 32nd Annual San Antonio Breast Cancer Symposium
Cytokinetics, 12/04/09
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis receives approval in the European Union for Onbrez Breezhaler, a new once-daily bronchodilator for patients with COPD
Novartis, 12/04/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
Article Search
Sponsor